SEC Form 4 · accession 0001179110-17-011394
ABIOMED INC · ABMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric A Rose M.D.
Director
Period of report
Aug 9, 2017
Accepted (ET)
Aug 11, 2017 · 4:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000815094
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.01 par valueF2 | Aug 9, 2017 | A | 1,283 | $0.00 | A | 14,542 | D | |
| Common Stock, $.01 par valueF3 | Aug 9, 2017 | F | 806 | $155.87 | D | 13,736 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $18.63 | holding | — | — | — | Aug 13, 2009 | Aug 13, 2018 | Common Stock | 0 | 12,000 | D |
| Stock Option (right to buy)F1 | $7.67 | holding | — | — | — | Aug 12, 2010 | Aug 12, 2019 | Common Stock | 0 | 12,000 | D |
Explanation of responses
- F1Grant to reporting person of option to buy shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- F2Represents shares underlying the grant of restricted stock units that are to be settled in common stock upon vesting. The restricted stock units will vest in full on the later of: (a) August 9, 2018; or (b) the date of the Issuer's next annual meeting of stockholders.
- F3Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with vesting of awards of restricted stock units